DOSSIER · 13F Holders · Q2 2026
BGMS
Cyclacel Pharmaceuticals Inc
5 institutions still hold Cyclacel Pharmaceuticals Inc as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 23254L876·5 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
5 institutions reported BGMS in Q2 2026. Tower Research Capital LLC (TRC) leads at 53.2% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.